EUVIMEDEUVIMED entdecken
Crossref

Intraoperative Cavity Local Delivery System with NETs‐Specific Drug Release for Post‐Breast Cancer Surgery Recurrence Correction

Wan-Fang Zhu, Wen-Jing Ji, Qiu-Yuan Wang, Wei Qu, Feng Feng, Ling-Fei Han, Jing-Wei Xue, Fu-Lei Liu, Wen-Yuan Liu iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202401537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Wan-Fang Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmceutical Analysis, China Pharmaceutical University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Hydrogels, Neoplasm Recurrence, Local, Transforming Growth Factor beta. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province of China, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postoperative breast cancer recurrence is tricky due to the limited therapeutic options. Transforming growth factors‐β (TGF‐β) is vital in promoting postoperative tumor recurrence. However, conventional blocking strategies fail to satisfy both bio‐safety and sufficient relapse correction. Neutrophil extracellular traps (NETs) are essential for the spatiotemporal dynamics of TGF‐β at tumor‐resection sites, whose unique mechanism for local TGF‐β amplification could remarkably increase the risk of relapse after surgery. Herein, the principle of NETs formation is ingeniously utilized to construct a surgical residual cavity hydrogel that mimics NETs formation. The hydrogel is prepared based on the electrostatic interaction between histidine (His) and sodium alginate (Alg). Then, arginine deiminase 4 (PAD4) protein is released during NETs formation. Simultaneously, the electrical property of His in hydrogel changes automatically, which further lead to promising localized release of anti‐TGF‐β. The hydrogel system can realize specific and selective drug release at targeted NETs site over a prolonged period while exhibiting excellent biocompatibility. Superior breast cancer recurrence inhibition is achieved by suppressing TGF‐β and related indicators, impeding epithelial‐mesenchymal transition (EMT) progression, and rectifying the locally exacerbated immunosuppressive environment within NETs. The novel NETs local microenvironment drug release functional hydrogel will provide inspiration for postoperative recurrence correction strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHydrogelsNeoplasm Recurrence, LocalTransforming Growth Factor betaAlginatesExtracellular TrapsFemaleHumansAnimalsDrug LiberationCell Line, TumorMiceEpithelial-Mesenchymal TransitionDrug Delivery SystemsProtein-Arginine Deiminase Type 4

Stichwörter der Autor:innen

NETs local microenvironment drug release functional hydrogelbreast cancerneutrophil extracellular traps (NETs)perioperativetransforming growth factors‐β (TGF‐β)

Substanzen

HydrogelsTransforming Growth Factor betaAlginatesProtein-Arginine Deiminase Type 4

Autor:innen und Institutionen

  • Department of Pharmceutical Analysis, China Pharmaceutical University, Nanjing, 210009, China.
  • College of Pharmacy, Changchun University of Chinese Medicine, Changchun, 130117, China.
  • Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing, 210009, China.
  • School of Pharmacy, Nanjing Medical University, Nanjing, 210029, China.
  • Tumor Precise Intervention and Translational Medicine Laboratory, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an, 271000, China.
  • Pharmaceutical Department, The Affiliated Taian City Central Hospital of Qingdao University, Tai'an, 271000, China.

ORCID-Profile: Wen-Yuan Liu

Förderung

  • Natural Science Foundation of Shandong Province of China
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhu, W. F., Ji, W. J., Wang, Q. Y., Qu, W., Feng, F., Han, L. F., Xue, J. W., Liu, F. L., & Liu, W. Y. (2024). Intraoperative Cavity Local Delivery System with NETs‐Specific Drug Release for Post‐Breast Cancer Surgery Recurrence Correction. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401537

Vancouver

Zhu WF, Ji WJ, Wang QY, Qu W, Feng F, Han LF, et al. Intraoperative Cavity Local Delivery System with NETs‐Specific Drug Release for Post‐Breast Cancer Surgery Recurrence Correction. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401537

BibTeX
@article{Zhu2024,
  author = {Zhu, Wan-Fang and Ji, Wen-Jing and Wang, Qiu-Yuan and Qu, Wei and Feng, Feng and Han, Ling-Fei and Xue, Jing-Wei and Liu, Fu-Lei and Liu, Wen-Yuan},
  title = {Intraoperative Cavity Local Delivery System with NETs‐Specific Drug Release for Post‐Breast Cancer Surgery Recurrence Correction},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202401537}
}
Kostenlos starten →